Benjamin A. Teply, MD

home / authors / benjamin-teply-md

Articles

Synovial Fluid in Checkpoint Inhibitor–Induced Inflammatory Arthritis

Mary Katherine L. Anderson, MD;James P. Fagerland, MD;Samantha Kohn, MD, MS;Amy C. Cannella, MD;Benjamin A. Teply, MD

May 16th 2025

This case report and literature review emphasize that ICI-IA should not be ruled out based on the presence of synovial fluid with elevated WBC with a neutrophil predominance. Early steroid use should be considered.

Navigating an Optimal Treatment Course for Advanced Kidney Cancer

Benjamin A. Teply, MD

June 20th 2021

Benjamin A. Teply, MD, considers the optimal treatment of renal cell carcinoma in a peer perspective accompanying an article by Tiffany Y. Shaw, MD, and colleagues.

Identification and Management of Toxicities From Immune Checkpoint–Blocking Drugs

Benjamin A. Teply, MD;Evan J. Lipson, MD

November 10th 2014

As immune checkpoint–blocking medications are administered to an increasing number of patients, clinicians must be able to recognize and treat the associated immune-related side effects.